SCHEMBL7797580

SCHEMBL7797580

CCOC(=O)C(CC(=O)c1cc(Cl)ccc1Cl)(NC=O)C(=O)OCC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERCC5 P28715 1/20 0.43
FEN1 P39748 1/20 0.43
TSHR P16473 2/20 0.43
TAS1R3 Q7RTX0 1/20 0.41
TAS1R1 Q7RTX1 1/20 0.41
ALDH1A1 P00352 5/20 0.41
MAPT P10636 5/20 0.41
LMNA P02545 1/20 0.41
KMT2A Q03164 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 2/20 0.39
TP53 P04637 2/20 0.39
ABCB11 O95342 1/20 0.39
HTR2A P28223 1/20 0.39
PMP22 Q01453 1/20 0.39
PPARA Q07869 1/20 0.39
HPGD P15428 2/20 0.38
CYP2C19 P33261 1/20 0.38
KDM4E B2RXH2 2/20 0.38
PKM P14618 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8654757 0.94 ERCC5 (0.43) ERCC5FEN1TSHRTAS1R3TAS1R1
SCHEMBL7797647 0.91 ALDH1A1 (0.46) ERCC5FEN1ALDH1A1MAPTLMNA
SCHEMBL7799510 0.85 LMNA (0.47) ERCC5FEN1TSHRALDH1A1MAPT
SCHEMBL7791499 0.85 CNR2 (0.41) TSHRALDH1A1MAPTLMNAKMT2A
SCHEMBL8656066 0.85 ALDH1A1 (0.46) ERCC5FEN1TSHRALDH1A1MAPT
SCHEMBL7799547 0.83 SMN1; SMN2 (0.45) ERCC5FEN1TSHRALDH1A1MAPT
SCHEMBL7797586 0.82 MAPT (0.45) TSHRALDH1A1MAPTLMNAHPGD
SCHEMBL7800768 0.81 MAPT (0.44) ERCC5FEN1ALDH1A1MAPTLMNA
SCHEMBL7797584 0.78 ERCC5 (0.42) ERCC5FEN1TSHRALDH1A1KMT2A
SCHEMBL9289811 0.77 ALDH1A1 (0.39) ERCC5FEN1TSHRTAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010008947-A1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES VARASI MARIO (IT) 2001-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010008947-A1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES KYNU, KMO, ABAT ERCC5 4102/4885FEN1 2873/4885TSHR 4661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.